Exam 3 - Migraines L30 Flashcards

(39 cards)

1
Q

Classes of drugs used for abortive therapy

A

1) Serotonin receptor agonists
2) Ergot alkaloids
3) Dopamine Receptor antagonists
4) Calcitonin gene-related peptide receptor antagonists
5) Analgesics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classes of drugs used for prophylactic therapy

A

1) beta-blockers
2) antidepressants
3) anticonvulsant drugs
4) calcitonin gene-related peptide ligand inhibitor
5) botulinum toxin type a
6) calcium channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Migraine background information

A

-about 44.5 million Americans suffer from migraines
-more women than men
-genetically linked
-costs American economy due to lost productiveness and healthcare costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the GI aspects of migraines?

A

-decreased GI motility and nausea/vomiting symptoms slow the oral absorption of drugs during a migraine
-parental routes of administration should be used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Due to the high variability of individual response to migraine drugs…

A

therapeutic strategies must be customized to each patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the phases of a migraine?

A

1) prodrome
2) aura
3) headache
4) postdrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe the prodrome phase

A

-present in less than 60% of patients
- changes in mood and appetite (cravings) that occur hours to days before migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe the aura phase

A

-aura classified as visual disturbances (fortification spectrum)
-occurs in less than 25% of people
-migraine without aura called common migraine
-migraine with aura called classic migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe the headache phase

A

-progression from dull ache to intense pulsations
-accompanied by GI symptoms (nausea and vomiting)
-photophobia and phonophobia sometimes present
-lasts 4-72 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe postdrome phase

A

characteristics of this phase differ among all people with migraines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are some other less common types of migraines?

A

-menstrual migraine
-tension type headache (not as bad as migraine, less symptoms)
-cluster headaches (very rare, intense pain, more common in males)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the proposed mechanisms of migrains

A

-vascular theory
-spreading depression
-serotonergic abnormalities
-p/q calcium channel mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe the vascular theory

A

aura is caused by vasoconstriction of vessels, and pain is caused by the vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe the spreading depression theory

A

migraines caused by the spreading decrease in cortical electrical activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe the serotonergic abnormalities mechanism

A

-mechanism not known, however it is known that IV injection of serotonin can abort a spontaneous or drug induced migraine
-some drugs work at serotonin receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are rebound headaches?

A

-migraines that are actually caused by increase use of drugs meant to treat migraines
-to avoid, abortive therapy drugs should only be used 2 times a week
-botox is only medication that can relieve these

17
Q

what are the analgesics drugs used in migraine treatment

A

-NSAIDS (aspirin, acetamenophen, ibuprofen)
-opiates (butorphanol)

18
Q

describe NSAID use in migraine treatment

A

-over the counter
-efficacy not clearly established
-mechanism of action appears to be related to blocking of prostaglandin synthesis and preventing inflammation
-use with caution in patients with renal problems and ulcers

19
Q

which symptoms is acetaminophen very effective in treating?

A

photophobia and phonophobia

20
Q

describe opiates in migraine treatment

A

-not often used, high abuse potential
-many adverse affects

21
Q

describe ergot alkaloids

A

-naturally occurring compounds found in grains contaminated by fungus
-historically the drug of choice for treatment
-oral, sublingual, suppository dosage form
-half life is 2 hours, but duration of action (vasoconstriction) is 24 hours
-sometimes mixed with caffeine or other alkaloids to avoid side effects

22
Q

what are the pharmacodynamics of ergot alkaloids

A

-activation of 5-HT1b receptors cause vasoconstriction
-activation of 5-HT1d reduces inflammation by decreasing release of substance P, neurokinin A, CGRP

23
Q

contraindications of ergot alkaloids

A

-cant be used in pregnant women or patients with peripheral vascular disease
-vasoconstriction can be potentiated by beta blockers in patients taking ergot alkaloids

24
Q

ergot alkaloid adverse reactions

A

-upsetting GI symptoms
-occurs in 10% of patients due to activation of dopamine receptors in chemoreceptor trigger zone
-may require adjunct therapy with antiemetic (10mg oral metoclopramide)

25
ergot alkaloid prototype
-dihydroergotamine (DHE 45) -administered parenterally or via nasal spray
26
chemistry and pharmacokinetics of triptans
-subcutaneous injection, oral tablets, nasal spray/powder or transdermal patch -metabolized by MAO-A, contraindicated with use of MAO inhibitor within 2 week time span -can be administered up to 4 hrs after onset of headache and still be effective
27
Triptan drugs
-first line drugs used for migraines -sumatriptan (1st gen, 1b/1d agonist) -zolmitriptan (2nd gen 1b/1d)
28
sumatriptan
-triptan drug -can be subcutaneous injection, oral tablet, nasal spray/powder, transdermal patch -type 1 serotonin receptor agonist (similar to to ergot alkaloid) -relieves nausea/vomiting and photo/phonophobia
29
toxicity and adverse reactions of triptans
-adverse cardiovascular symptoms -several fatalities reported due to subcutaneous injection of triptans resulting in MIs -do NOT give IV -Do not give within 24 hours of ergot alkaloid
30
describe 2nd gen triptans
-act at the peripheral components of the trigeminovascular symptoms (like 1st gen) -greater lipid solubility leads to them acting centrally to inhibit pain transmission in trigeminal nucleus -better oral absorption
31
describe dopamine receptor antagonists
-metoclopramide, prochlorperazine, and chlorpromazine -useful when triptans, DHE, and analgesics don't work -given by IV in emergency departments -relieve headaches and have anti-emetic activity
32
when to consider prophylactic drug therapy
-when patients don't respond to acute therapies and have more than 3 migraines a week -need to be tried for 2-3 months before being considered ineffective -should only use for 3-6 months then stop
33
beta blockers
-propanolol, metoprolol, timolol -prophylactic drugs -mechanism of action not clear (serotonin related?) -b-blockers with intrinsic sympathomimetic activity not effective
34
antidepressants
-amitriptyline -prophylactic drug -mechanism of action unknown, but independent from antidepressant action -sedation and anticholinergic side effects present
35
anticonvulsants
-topiramate -prophylactic drugs -mechanism of action unknown, perhaps GABA transmission? -topiramate has some side effects (paresthesia, fatigue, anorexia/nausea, diarrhea, weight loss, cognitive problems)
36
CGPR ligand inhibitors
-prophylactic drugs -rimegepant is also used for acute treatment -mab suffix denotes human monoclonal antibodies -modest effects shown in clinical trials
37
botulinum toxin A
-prophylactic drug -also used for cosmetics -only medication for rebound headaches -anti migraine effect can last for up to 3 months
38
calcium channel blockers
-prophylactic drugs -less effective than other drugs, last resort
39
migraines in children
-shorter duration of pain (30 min) -1st step is to eliminate possible food triggers